Femasys (NASDAQ:FEMY) Trading Down 14.6% – Time to Sell?

Femasys Inc. (NASDAQ:FEMY) fell 14.6% on Thursday . The stock traded as low as $3.04 and last traded at $3.05. 43,437 shares changed hands during trading, an increase of 38% from the average daily volume of 31,380 shares. The stock had previously closed at $3.57.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Weiss Ratings raised Femasys from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, June 3rd. Wall Street Zen raised Femasys to a “hold” rating in a research note on Saturday, June 13th. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $106.67.

Femasys Price Performance

The company has a fifty day simple moving average of $5.53 and a 200 day simple moving average of $8.67. The stock has a market capitalization of $9.21 million, a price-to-earnings ratio of -0.56 and a beta of -2.13. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.98 and a current ratio of 3.91.

Femasys (NASDAQ:FEMY) last issued its quarterly earnings results on Friday, May 8th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($1.33) by $1.43. Femasys had a negative return on equity of 258.08% and a negative net margin of 521.97%.The company had revenue of $0.42 million during the quarter, compared to analysts’ expectations of $0.77 million.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in FEMY. Banco BTG Pactual S.A. acquired a new stake in shares of Femasys during the fourth quarter worth $88,000. Geode Capital Management LLC lifted its holdings in Femasys by 50.8% in the fourth quarter. Geode Capital Management LLC now owns 389,280 shares of the company’s stock valued at $224,000 after buying an additional 131,052 shares during the period. Jane Street Group LLC acquired a new position in Femasys in the fourth quarter valued at $62,000. Cetera Investment Advisers bought a new stake in Femasys during the fourth quarter valued at $36,000. Finally, HRT Financial LP bought a new stake in Femasys during the fourth quarter valued at $30,000. Institutional investors own 65.27% of the company’s stock.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.